Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Feb. 27, 2015, 94 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $312.37 to $25,006,808.00.

Highlighted Stocks Traded by Insiders:

TJX Companies (TJX) - FREE Research Report

Meyrowitz Carol, who is Ceo - Tjx at TJX Companies, sold 132,555 shares at $68.22 on Feb. 27, 2015. Following this transaction, the Ceo - Tjx owned 619,086 shares meaning that the stake was reduced by 17.64% with the 132,555-share transaction.

Goldenberg Scott, who is Sevp, Cfo at TJX Companies, sold 4,667 shares at $68.42 on Feb. 27, 2015. Following this transaction, the Sevp, Cfo owned 68,672 shares meaning that the stake was reduced by 6.36% with the 4,667-share transaction.

The shares most recently traded at $69.37, up $0.95, or 1.37% since the insider transaction. Historical insider transactions for TJX Companies go as follows:

  • 4-Week # shares sold: 4,771
  • 12-Week # shares bought: 31,656
  • 12-Week # shares sold: 4,771
  • 24-Week # shares bought: 31,656
  • 24-Week # shares sold: 38,475

The average volume for TJX Companies has been 3.3 million shares per day over the past 30 days. TJX Companies has a market cap of $46.9 billion and is part of the services sector and retail industry. Shares are up 0.09% year-to-date as of the close of trading on Friday.

The TJX Companies, Inc. operates as an off-price apparel and home fashions retailer in the United States and internationally. The company operates in four segments: Marmaxx, HomeGoods, TJX Canada, and TJX Europe. The stock currently has a dividend yield of 1.03%. The company has a P/E ratio of 21.6. Currently, there are 11 analysts who rate TJX Companies a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TJX - FREE

TheStreet Quant Ratings rates TJX Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full TJX Companies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cardiovascular Systems (CSII) - FREE Research Report

Kenny Kevin J, who is Chief Operating Officer at Cardiovascular Systems, sold 2,294 shares at $37.00 on Feb. 27, 2015. Following this transaction, the Chief Operating Officer owned 66,609 shares meaning that the stake was reduced by 3.33% with the 2,294-share transaction.

The shares most recently traded at $38.55, up $1.55, or 4.02% since the insider transaction. Historical insider transactions for Cardiovascular Systems go as follows:

  • 4-Week # shares sold: 27,044
  • 12-Week # shares sold: 42,081
  • 24-Week # shares bought: 10,250
  • 24-Week # shares sold: 48,766

The average volume for Cardiovascular Systems has been 231,200 shares per day over the past 30 days. Cardiovascular Systems has a market cap of $1.2 billion and is part of the health care sector and health services industry. Shares are up 25.37% year-to-date as of the close of trading on Friday.

Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. Currently, there are 7 analysts who rate Cardiovascular Systems a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSII - FREE

TheStreet Quant Ratings rates Cardiovascular Systems as a sell. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity. Get the full Cardiovascular Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

PDF Solutions (PDFS) - FREE Research Report

Kim KwangH, who is VP of Business Development at PDF Solutions, sold 100 shares at $18.68 on Feb. 27, 2015. Following this transaction, the VP of Business Development owned 14,900 shares meaning that the stake was reduced by 0.67% with the 100-share transaction.

The shares most recently traded at $18.44, down $0.24, or 1.3% since the insider transaction. Historical insider transactions for PDF Solutions go as follows:

  • 4-Week # shares sold: 2,319
  • 12-Week # shares sold: 2,319
  • 24-Week # shares sold: 2,319

The average volume for PDF Solutions has been 252,800 shares per day over the past 30 days. PDF Solutions has a market cap of $581.4 million and is part of the technology sector and computer software & services industry. Shares are up 22.07% year-to-date as of the close of trading on Friday.

PDF Solutions, Inc. provides infrastructure technologies and services to enhance yield and optimize performance of integrated circuits (IC) in Asia, Europe and North America. The company has a P/E ratio of 17.7. Currently, there are 3 analysts who rate PDF Solutions a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PDFS - FREE

TheStreet Quant Ratings rates PDF Solutions as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full PDF Solutions Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null